4.5 Article

Serum zinc and dietary intake of zinc in relation to risk of different breast cancer subgroups and serum levels as a marker of intake: a prospective nested case-control study

期刊

BREAST CANCER RESEARCH AND TREATMENT
卷 189, 期 2, 页码 571-583

出版社

SPRINGER
DOI: 10.1007/s10549-021-06318-0

关键词

Breast cancer; Zinc; Subgroups; Serum; Diet

类别

资金

  1. Lund University. Region Skane
  2. Malmo University Hospital Funds and Donations
  3. Malmo University Hospital Research Fund
  4. Einar and Inga Nilsson Foundation
  5. Ernhold Lundstrom Foundation
  6. Gunnar Nilsson Cancer Foundation
  7. Swedish Cancer Society

向作者/读者索取更多资源

The study found no significant association between zinc levels in serum or pre-diagnostic diet and the risk of breast cancer, as well as no clear associations between zinc and any breast cancer characteristics. Additionally, the results suggest that serum zinc is a poor marker of zinc intake.
Purpose Zinc has been suggested to be protective against breast cancer, but the evidence remains inconclusive. One reason for inconsistent findings in previous studies may be that zinc only influences the risk of developing certain subtypes of breast cancer. Our study is the first study assessing zinc levels in relation to the risk of different breast cancer subgroups, defined by their tumor characteristics. In addition, we analyze serum zinc as a marker of dietary intake. Methods The Malmo Diet and Cancer Study is a population-based cohort study that took place 1991-1996 in Malmo, Sweden. Until end of follow-up, 31 December 2013, 1186 incident cases were identified and matched to an equal number of controls. Odds ratios (ORs) for breast cancer, and having a certain tumor characteristic, were estimated in quartiles of baseline serum zinc and zinc intake and adjusted for potential confounders. Results No associations were found between zinc, measured in serum or diet pre-diagnostically, and breast cancer risk. The adjusted OR for breast cancer in serum zinc Q4 compared to Q1 was 1.09 (0.85-1.41) and in zinc intake Q4 versus Q1 was 0.97 (0.77-1.23). Moreover, there were no clear associations between zinc and any breast cancer characteristics. The kappa value, 0.025 (P = 0.022), showed poor agreement between serum zinc and zinc intake. Conclusion Our findings indicate that there is no clear association between zinc and overall breast cancer risk or risk of different breast cancer subgroups. Finally, our results suggest that serum zinc is a poor marker of zinc intake.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据